Welcome to TALK BEFORE YOU TAKE

Featured Videos                                                                                   Just Released!

Talk Before You TakePocket Guide/Brochure(download English PDF)NEW! Habla Antes de TomarlasPocket Guide/Brochure(download Spanish PDF)“Talk Before You Take”—a simple message that conveys the importance of talking about the benefits and risks of prescribed medications before a prescription is written and filled. When healthcare providers convey important information about prescribed medications, there is sometimes no guarantee that patients fully understand both the benefits and potential risks of starting the treatment. As proof, how often do we walk out of a doctor’s office asking, “What did the doctor or nurse say again about this medicine?”

 

Increasing communication about prescriptions can help patients:

 

  • Understand medication side effects—for example, which ones, if any, will go away with time and those that may be experienced for the duration of being on the medicine.
  • Avoid adverse drug reactions.
  • Improve adherence to medicine regimen(s).
  • Live healthier lives.

 

TalkBeforeYouTake.org provides free, downloadable tools in English and Spanish that patients and healthcare providers can use to spark better and more effective medicine communication.

 

Just released in July 2016 — a great new tool for Healthcare Providers. 
Talk Before You Take Powerpoint: Presentation for Community Education.

BeMedWise Program at NeedyMeds

 

50 Whittemore St., PO Box 219

Gloucester, MA 01931

Phone: (978) 281-6666

Fax: (206) 260-8850

 

Email: [email protected]

 

Websites:

BeMedWise.org

TalkBeforeYouTake.org

 

BeMedWise Program at NeedyMeds, formerly known as the National Council on Patient Information and Education (NCPIE), encourages healthcare professionals and community groups to foster patient-professional communication about medicines.  However, BeMedWise does not supervise or endorse the activities of any group or professional.  Discussion and action concerning medicines are solely the responsibility of the patient and their healthcare professionals, and not BeMedWise.

 

 

 

 

 

 

 

 

BeMedWise wishes to acknowledge that this work was supported by the U.S. Food and Drug Administration, Center for Drug Evaluation and Research under grant number 5U18FD004653. The content is solely the responsibility of BeMedWise and does not necessarily represent the official views of the Food and Drug Administration.